Tag: antitrust generic substitution

Explore how drug makers use product hopping and REMS abuse to block generic substitution, violating antitrust laws. Learn about key cases like NY v. Actavis and the billions in costs to consumers.

Recent-posts

JAK Inhibitors: What Infections and Blood Clots to Watch For

Jan, 16 2026

Clomiphene and Male Infertility: What Are the Real Benefits?

Nov, 1 2025

Labeling Effect: How Generic Drug Labels Influence Pain, Adherence, and Perceived Efficacy

Jan, 26 2026

How Doctors Around the World View Generic Medications

Jan, 20 2026

Managing Warfarin and Antibiotic Interactions: Preventing INR Spikes

Apr, 17 2026